knowledge -WSS

knowledge

author：fashion 2025-09-02 09:40:32 - browse：7

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Four alarming medical procedures we’re glad history forgot

hotspot

WSS

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Can medical device makers keep up in the race to treat obesity?

Oral obesity drug from Viking Therapeutics hits key early target

FDA approves first new drug developed for postpartum depression

Inside the rise of 'mukbang' eating videos

Timeline: Key moments in fight for gay rights

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Moonlake's readout produced a cash windfall. Risks remain

Living organ donors deserve priority status for transplants

Peter Hotez and the public health issue of online harassment

Gut bacteria may contribute to kidney autoimmunity, study finds

Trump demands the U.S. pay no more for drugs than other countries … again

Millions may soon lose Medicaid when they don't have to

Trump demands the U.S. pay no more for drugs than other countries … again

Mass General Brigham physicians react to latest merger step

State Dept. review finds Biden bears some blame for Afghanistan failures

Florida Supreme Court upholds state's abortion ban

leisure time

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Biogen nominates mother of director’s child to replace him on board

First Opinion on colorectal cancer screening: letter and response

Timeline: Key moments in fight for gay rights

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Timeline: Key moments in fight for gay rights

entertainment

leisure time

hotspot

leisure time